Skip to contentOpaleye Management Inc. — Tracon Pharmaceuticals, Inc. insider: 494 transactions · InsiderLensOpaleye Management Inc.
- Former 10% Owner. at TELA Bio, Inc. · on record since Apr 20, 2023
- 10% owner at CODEXIS INC · on record since Sep 26, 2024
- 10% owner at RUB MUSIC ENTERPRISES, INC. · on record since Apr 21, 2026
- 10% owner at Sol-Gel Technologies Ltd. · on record since May 14, 2026
- 10% owner at Alpha Cognition Inc. · on record since May 19, 2026
- 10% owner at TRANSDEL PHARMACEUTICALS INC · on record since Jun 30, 2015
- 10% owner at OCULAR THERAPEUTIX, INC · on record since Dec 27, 2019
- 10% owner at Eton Pharmaceuticals, Inc. · on record since Apr 6, 2020
- Previously a 10% owner at OCULAR THERAPEUTIX, INC · on record since Apr 3, 2020
- 10% owner at Tracon Pharmaceuticals, Inc. · on record since Aug 31, 2020
- 10% owner at Protara Therapeutics, Inc. · on record since Sep 25, 2020
- 10% owner at TELA Bio, Inc. · on record since Jun 30, 2022
Insider trading activity of Opaleye Management Inc.
- Transactions on record
- 494
- since May 20, 2015
- Open-market buys
- 361
- $61M
- Open-market sells
- 130
- $35.7M
- Companies traded
- 10
- last filing Jul 2, 2026
Figures computed from official regulatory filings — methodology.
Companies where Opaleye Management Inc. has traded
- Sol-Gel Technologies Ltd.30 tx · $7.1M · Jul 2, 2026
- Alpha Cognition Inc.41 tx · $3.2M · Jun 29, 2026
- RUB MUSIC ENTERPRISES, INC.19 tx · $2.9M · May 4, 2026
- TRANSDEL PHARMACEUTICALS INC80 tx · $24.1M · Mar 5, 2026
- CODEXIS INC71 tx · $21.3M · Dec 15, 2025
- Eton Pharmaceuticals, Inc.50 tx · $14.9M · Jun 12, 2025
- Protara Therapeutics, Inc.73 tx · $8.6M · Sep 12, 2024
- Tracon Pharmaceuticals, Inc.89 tx · $12.8M · Nov 14, 2023
- TELA Bio, Inc.38 tx · $4M · Nov 4, 2022
Track record of Opaleye Management Inc.
Statistical track record
Free- Open-market buys
- 362
- Last buy
- Jul 2, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Opaleye Management Inc.
Co-insiders of Opaleye Management Inc.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · $137.9K · Jan 3, 2020
Abrams Jeffrey JTRANSDEL PHARMACEUTICALS INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 2, 2026 | Buy | 1,400 | 71.97 USD | — | SEC |
| Jul 2, 2026 | Buy | 312 | 71.99 USD | — | SEC |
| Jun 29, 2026 | Buy | 197 | 6.50 USD | — | SEC |
| Jun 29, 2026 | Buy | 152,336 | 6.40 USD | — | SEC |
| Jun 15, 2026 | Buy | 2,862 | 5.91 USD | $16.9K | SEC |
| Jun 15, 2026 | Buy | 273 | 5.93 USD | $1.6K | SEC |
| Jun 15, 2026 | Buy | 4,550 | 5.99 USD | $27.3K | SEC |
| Jun 11, 2026 | Buy | 5,872 | 5.99 USD | $35.2K | SEC |
| Jun 11, 2026 | Buy | 24,856 | 5.98 USD | $148.5K | SEC |
| Jun 9, 2026 | Buy | 10,054 | 5.83 USD | $58.6K | SEC |
| May 29, 2026 | Buy | 2,000 | 5.83 USD | $11.7K | SEC |
| May 29, 2026 | Buy | 1,161 | 5.73 USD | $6.7K | SEC |
| May 29, 2026 | Buy | 70,577 | 5.90 USD | $416.4K | SEC |
| May 22, 2026 | Buy | 15,945 | 5.70 USD | $90.9K | SEC |
| May 22, 2026 | Buy | 8,431 | 5.89 USD | $49.7K | SEC |
| May 22, 2026 | Buy | 1,563 | 64.43 USD | $100.7K | SEC |
| May 19, 2026 | Buy | 16,648 | 5.83 USD | $97K | SEC |
| May 19, 2026 | Buy | 17,395 | 5.69 USD | $99K | SEC |
| May 14, 2026 | Buy | 1,937 | 66.87 USD | $129.5K | SEC |
| May 14, 2026 | Buy | 1,500 | 67.98 USD | $102K | SEC |
| May 4, 2026 | Sell | -500 | 16.11 USD | $8.1K | SEC |
| May 4, 2026 | Sell | -1,000 | 16.15 USD | $16.2K | SEC |
| May 4, 2026 | Sell | -24,000 | 16.15 USD | $387.6K | SEC |
| May 4, 2026 | Sell | -10,081 | 16.11 USD | $162.4K | SEC |
| Apr 30, 2026 | Sell | -1,000 | 17.25 USD | $17.2K | SEC |